Connect with us

Hi, what are you looking for?

Investing

Stocks to Watch: Apellis Pharmaceuticals

By Sabela Ojea


Apellis Pharmaceuticals on Tuesday provided an update on the eye-disease drug Syfovre, which has been dogged by safety concerns in recent weeks. Shares of the biopharmaceutical company surged 31%, to $40.35, in after-hours trading.


Write to Sabela Ojea at [email protected]

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

News

This article was written by Follow Bret Jensen has over 13 years as a market analyst, helping investors find big winners in the biotech...

Videos

Watch full video on YouTube